Eli Lilly to acquire Versanis for $1.9 billion in an obesity drug push
HQ Team July `4, 2023: Eli Lilly and Company will acquire private Versanis for $ 1.93 billion in cash to expand its portfolio.
Drugs
Health
Pharma
Drugs
Health
Pharma
Global diabetic population may more than double by 2050
HQ Team June 23, 2023: The global population of people living with diabetes may more than double to 1.3 billion from the current.
Drugs
Health
Pharma
AstraZeneca signs $2 billion deal for autoimmune diseases
HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to.
Drugs
Health
Medical
Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals
HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.
Drugs
Health
Pharma
Eli Lilly to sell diabetic nasal drug to Amphastar for $1.07 billion
Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.
Drugs
Medical
Pharma
Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Pharma
Dr. Reddy divests dermatology brands to Eris for INR 2.7b
India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.
Drugs
Pharma
Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.